Publicacións (83) Publicacións nas que participase algún/ha investigador/a

2020

  1. 5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Optimization of Parkinson's Treatment

    Parkinson's Disease, Vol. 2020

  2. A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis

    Multiple Sclerosis Journal, Vol. 26, Núm. 9, pp. 1074-1082

  3. Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 75, Núm. 3, pp. 416-424

  4. Alopecia in Meralgia Paresthetica

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 1, pp. 69

  5. Angiotensin AT1and AT2receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia

    Journal of Neuroinflammation, Vol. 17, Núm. 1

  6. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

    Brain, Behavior, and Immunity, Vol. 87, pp. 256-271

  7. Antihyperthermic treatment decreases perihematomal hypodensity

    Neurology, Vol. 94, Núm. 16, pp. E1738-E1748

  8. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

    Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

  9. Blood biomarkers predictive of epilepsy after an acute stroke event

    Epilepsia, Vol. 61, Núm. 10, pp. 2244-2253

  10. Cerebellar Cognitive Affective Syndrome in Costa da Morte Ataxia (SCA36)

    Cerebellum, Vol. 19, Núm. 4, pp. 501-509

  11. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36

    Neuron, Vol. 107, Núm. 2, pp. 292-305.e6

  12. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

    Frontiers in Neurology, Vol. 11

  13. Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome

    Revista de Neurologia, Vol. 71, Núm. 6, pp. 221-224

  14. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset

    Neurology, Vol. 94, Núm. 11, pp. e1171-e1180

  15. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

  16. Consensus statement for the management of generalized tonic-clonic seizures in Spain

    Acta Neurologica Scandinavica, Vol. 141, Núm. 1, pp. 22-32

  17. Constraint-induced movement therapy in the rehabilitation of hemineglect after a stroke

    Revista de Neurologia, Vol. 70, Núm. 4, pp. 119-126

  18. Correlation between regional brain atrophy, cognitive function, adipose tissue and CSF biomarkers in mild cognitive impairment

    Alzheimer's & Dementia, Vol. 16, Núm. S4

  19. Correlation of blood biomarkers with early-onset seizures after an acute stroke event

    Epilepsy and Behavior, Vol. 104

  20. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119